Mohsen Khademi

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BRAIN AND BEHAVIOR. 2023;13(1):e2873

Demographic and disease-related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis.

Zondra Revendova K; Starvaggi Cucuzza C; Manouchehrinia A; Khademi M; Bar M; Leppert D; Sandberg E; Ouellette R; Granberg T; Piehl F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2022;29(11):3317-3328

B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients.

Asplund Högelin K; Ruffin N; Pin E; Hober S; Nilsson P; Starvaggi Cucuzza C; Khademi M; Olsson T; Piehl F; Al Nimer F
Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(7):962-976

Copy number variations across the blood-brain barrier in multiple sclerosis.

Bedri SK; Evertsson B; Khademi M; Al Nimer F; Olsson T; Hillert J; Glaser A
Article: SCIENCE ADVANCES. 2022;8(17):eabn1823

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.

Bronge M; Högelin KA; Thomas OG; Ruhrmann S; Carvalho-Queiroz C; Nilsson OB; Kaiser A; Zeitelhofer M; Holmgren E; Linnerbauer M; Adzemovic MZ; Hellström C; Jelcic I; Liu H; Nilsson P; Hillert J; Brundin L; Fink K; Kockum I; Tengvall K; Martin R; Tegel H; Gräslund T; Al Nimer F; Guerreiro-Cacais AO; Khademi M; Gafvelin G; Olsson T; Grönlund H
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:930947

Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy.

Papapavlou Lingehed G; Hellberg S; Huang J; Khademi M; Kockum I; Carlsson H; Tjernberg I; Svenvik M; Lind J; Blomberg M; Vrethem M; Mellergård J; Gustafsson M; Jenmalm MC; Olsson T; Ernerudh J
Article: EPIGENOMICS. 2021;13(20):1607-1618

Deep characterization of paired chromatin and transcriptomes in four immune cell types from multiple sclerosis patients.

Fernandes SJ; Ericsson M; Khademi M; Jagodic M; Olsson T; Gomez-Cabrero D; Kockum I; Tegnér J
Article: ISCIENCE. 2021;24(9):103078

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis.

Asplund Högelin K; Ruffin N; Pin E; Månberg A; Hober S; Gafvelin G; Grönlund H; Nilsson P; Khademi M; Olsson T; Piehl F; Al Nimer F
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(17):e2011574118

Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.

Zheleznyakova GY; Piket E; Needhamsen M; Hagemann-Jensen M; Ekman D; Han Y; James T; Khademi M; Al Nimer F; Scicluna P; Huang J; Kockum I; Faridani OR; Olsson T; Piehl F; Jagodic M
Article: MOLECULAR & CELLULAR PROTEOMICS. 2021;20:100157

Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers.

Huang J; Khademi M; Lindhe Ö; Jönsson G; Piehl F; Olsson T; Kockum I
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2020;8(1):207

Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS.

Gerhards R; Pfeffer LK; Lorenz J; Starost L; Nowack L; Thaler FS; Schlüter M; Rübsamen H; Macrini C; Winklmeier S; Mader S; Bronge M; Grönlund H; Feederle R; Hsia H-E; Lichtenthaler SF; Merl-Pham J; Hauck SM; Kuhlmann T; Bauer IJ; Beltran E; Gerdes LA; Mezydlo A; Bar-Or A; Banwell B; Khademi M; Olsson T; Hohlfeld R; Lassmann H; Kümpfel T; Kawakami N; Meinl E
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2020;7(4):e775

Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.

Duell F; Evertsson B; Al Nimer F; Sandin Å; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(23):12952-12960

Inflammation-related plasma and CSF biomarkers for multiple sclerosis.

Huang J; Khademi M; Fugger L; Lindhe Ö; Novakova L; Axelsson M; Malmeström C; Constantinescu C; Lycke J; Piehl F; Olsson T; Kockum I
Article: NEUROLOGY. 2020;94(23):e2457-e2467

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis.

Manouchehrinia A; Stridh P; Khademi M; Leppert D; Barro C; Michalak Z; Benkert P; Lycke J; Alfredsson L; Kappos L; Piehl F; Olsson T; Kuhle J; Kockum I
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27(2):297-307

Epilepsy in systemic lupus erythematosus: prevalence and risk factors.

Hopia L; Andersson M; Svenungsson E; Khademi M; Piehl F; Tomson T
Article: SCIENTIFIC REPORTS. 2019;9(1):11996

Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients.

Fernandes SJ; Morikawa H; Ewing E; Ruhrmann S; Joshi RN; Lagani V; Karathanasis N; Khademi M; Planell N; Schmidt A; Tsamardinos I; Olsson T; Piehl F; Kockum I; Jagodic M; Tegnér J; Gomez-Cabrero D
Article: JOURNAL OF IMMUNOLOGY. 2019;203(4):888-898

IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis.

Lindahl H; Guerreiro-Cacais AO; Bedri SK; Linnerbauer M; Lindén M; Abdelmagid N; Tandre K; Hollins C; Irving L; Glover C; Jones C; Alfredsson L; Rönnblom L; Kockum I; Khademi M; Jagodic M; Olsson T
Article: JOURNAL OF AUTOIMMUNITY. 2019;102:38-49

Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis.

Bronge M; Ruhrmann S; Carvalho-Queiroz C; Nilsson OB; Kaiser A; Holmgren E; Macrini C; Winklmeier S; Meinl E; Brundin L; Khademi M; Olsson T; Gafvelin G; Grönlund H
Article: NATURE MEDICINE. 2019;25(8):1290-1300

GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis.

Galli E; Hartmann FJ; Schreiner B; Ingelfinger F; Arvaniti E; Diebold M; Mrdjen D; van der Meer F; Krieg C; Nimer FA; Sanderson N; Stadelmann C; Khademi M; Piehl F; Claassen M; Derfuss T; Olsson T; Becher B
Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):60

Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.

Estelius J; Lengqvist J; Ossipova E; Idborg H; Le Maître E; Andersson MLA; Brundin L; Khademi M; Svenungsson E; Jakobsson P-J; Lampa J
Article: EBIOMEDICINE. 2019;40:517-527

B cell alterations during BAFF inhibition with belimumab in SLE.

Ramsköld D; Parodis I; Lakshmikanth T; Sippl N; Khademi M; Chen Y; Zickert A; Mikeš J; Achour A; Amara K; Piehl F; Brodin P; Gunnarsson I; Malmström V
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;49(2):313-322

miR-31 regulates energy metabolism and is suppressed in T cells from patients with Sjögren's syndrome.

Johansson A; Nyberg WA; Sjöstrand M; Moruzzi N; Bergman P; Khademi M; Andersson M; Piehl F; Berggren P-O; Covacu R; Jagodic M; Espinosa A
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2715

Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.

Engdahl E; Gustafsson R; Huang J; Biström M; Lima Bomfim I; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A
Article: CELL. 2018;175(1):85-100.e23

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

Jelcic I; Al Nimer F; Wang J; Lentsch V; Planas R; Jelcic I; Madjovski A; Ruhrmann S; Faigle W; Frauenknecht K; Pinilla C; Santos R; Hammer C; Ortiz Y; Opitz L; Grönlund H; Rogler G; Boyman O; Reynolds R; Lutterotti A; Khademi M; Olsson T; Piehl F; Sospedra M; Martin R
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2018;5(5):e491

Identification of MS-specific serum miRNAs in an international multicenter study.

Regev K; Healy BC; Paul A; Diaz-Cruz C; Mazzola MA; Raheja R; Glanz BI; Kivisäkk P; Chitnis T; Jagodic M; Piehl F; Olsson T; Khademi M; Hauser S; Oksenberg J; Khoury SJ; Weiner HL; Gandhi R
Article: MULTIPLE SCLEROSIS JOURNAL. 2018;24(8):1046-1054

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.

Piehl F; Kockum I; Khademi M; Blennow K; Lycke J; Zetterberg H; Olsson T
Article: HUMAN MOLECULAR GENETICS. 2018;27(5):912-928

Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients.

James T; Lindén M; Morikawa H; Fernandes SJ; Ruhrmann S; Huss M; Brandi M; Piehl F; Jagodic M; Tegnér J; Khademi M; Olsson T; Gomez-Cabrero D; Kockum I
Article: NEUROLOGY. 2017;89(22):2230-2237

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.

Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
Article: VIRAL IMMUNOLOGY. 2017;30(8):590-600

Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.

Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å
Article: JOURNAL OF NEUROCHEMISTRY. 2017;141(2):296-304

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.

Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmeström C; Piehl F; Olsson T; Lycke J
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(1):62-71

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.

Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmeström C; Piehl F; Olsson T; Lycke J
Article: AUTOIMMUNITY. 2016;49(6):421-433

Autoantibody targets in vaccine-associated narcolepsy.

Häggmark-Månberg A; Zandian A; Forsström B; Khademi M; Lima Bomfim I; Hellström C; Arnheim-Dahlström L; Hallböök T; Darin N; Lundberg IE; Uhlén M; Partinen M; Schwenk JM; Olsson T; Nilsson P
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(4):e256

Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.

Lam MA; Maghzal GJ; Khademi M; Piehl F; Ratzer R; Romme Christensen J; Sellebjerg FT; Olsson T; Stocker R
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016;113(28):7864-7869

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Brändle SM; Obermeier B; Senel M; Bruder J; Mentele R; Khademi M; Olsson T; Tumani H; Kristoferitsch W; Lottspeich F; Wekerle H; Hohlfeld R; Dornmair K
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(3):e219

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.

Bergman P; Piket E; Khademi M; James T; Brundin L; Olsson T; Piehl F; Jagodic M
Article: CLINICAL IMMUNOLOGY. 2016;166-167:89-95

Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.

Lindblom RPF; Aeinehband S; Ström M; Al Nimer F; Sandholm K; Khademi M; Nilsson B; Piehl F; Ekdahl KN
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016;113(8):2188-2193

Anoctamin 2 identified as an autoimmune target in multiple sclerosis.

Ayoglu B; Mitsios N; Kockum I; Khademi M; Zandian A; Sjöberg R; Forsström B; Bredenberg J; Lima Bomfim I; Holmgren E; Grönlund H; Guerreiro-Cacais AO; Abdelmagid N; Uhlén M; Waterboer T; Alfredsson L; Mulder J; Schwenk JM; Olsson T; Nilsson P
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(1):e191

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.

Al Nimer F; Elliott C; Bergman J; Khademi M; Dring AM; Aeinehband S; Bergenheim T; Romme Christensen J; Sellebjerg F; Svenningsson A; Linington C; Olsson T; Piehl F
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2016;87(2):126-129

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.

Disanto G; Adiutori R; Dobson R; Martinelli V; Dalla Costa G; Runia T; Evdoshenko E; Thouvenot E; Trojano M; Norgren N; Teunissen C; Kappos L; Giovannoni G; Kuhle J; International Clinically Isolated Syndrome Study G
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;51:47-55

Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.

Aeinehband S; Brenner P; Ståhl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Article: PLOS ONE. 2016;11(5):e0155832

Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis.

Abdelmagid N; Bereczky-Veress B; Atanur S; Musilová A; Zídek V; Saba L; Warnecke A; Khademi M; Studahl M; Aurelius E; Hjalmarsson A; Garcia-Diaz A; Denis CV; Bergström T; Sköldenberg B; Kockum I; Aitman T; Hübner N; Olsson T; Pravenec M; Diez M
Article: JOURNAL OF NEUROINFLAMMATION. 2015;12:235

Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.

Wuhrer M; Selman MHJ; McDonnell LA; Kümpfel T; Derfuss T; Khademi M; Olsson T; Hohlfeld R; Meinl E; Krumbholz M
Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(10):1271-1279

Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.

Checa A; Khademi M; Sar DG; Haeggström JZ; Lundberg JO; Piehl F; Olsson T; Wheelock CE
Article: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):264-276

Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.

Ambati A; Poiret T; Svahn B-M; Valentini D; Khademi M; Kockum I; Lima I; Arnheim-Dahlström L; Lamb F; Fink K; Meng Q; Kumar A; Rane L; Olsson T; Maeurer M
Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(8):1013-1024

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier U-C; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
Article: NATURE COMMUNICATIONS. 2015;6:7333

γ-Secretase directly sheds the survival receptor BCMA from plasma cells.

Laurent SA; Hoffmann FS; Kuhn P-H; Cheng Q; Chu Y; Schmidt-Supprian M; Hauck SM; Schuh E; Krumbholz M; Rübsamen H; Wanngren J; Khademi M; Olsson T; Alexander T; Hiepe F; Pfister H-W; Weber F; Jenne D; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
Article: BRAIN. 2015;138(Pt 4):918-931

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
Article: JOURNAL OF IMMUNOLOGY. 2015;194(2):542-552

The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.

Hoffmann FS; Kuhn P-H; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister H-W; Alexander T; Hiepe F; Kümpfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
Article: PLOS ONE. 2015;10(4):e0122048

Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.

Aeinehband S; Lindblom RPF; Al Nimer F; Vijayaraghavan S; Sandholm K; Khademi M; Olsson T; Nilsson B; Ekdahl KN; Darreh-Shori T; Piehl F
Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(1):48-56

Age-dependent effects on the treatment response of natalizumab in MS patients.

Matell H; Lycke J; Svenningsson A; Holmén C; Khademi M; Hillert J; Olsson T; Piehl F
Article: JOURNAL OF PROTEOME RESEARCH. 2014;13(11):4607-4619

Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis.

Byström S; Ayoglu B; Häggmark A; Mitsios N; Hong M-G; Drobin K; Forsström B; Fredolini C; Khademi M; Amor S; Uhlén M; Olsson T; Mulder J; Nilsson P; Schwenk JM
Article: NATURE COMMUNICATIONS. 2014;5:5056

Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.

Hartmann FJ; Khademi M; Aram J; Ammann S; Kockum I; Constantinescu C; Gran B; Piehl F; Olsson T; Codarri L; Becher B
Article: JOURNAL OF AUTOIMMUNITY. 2014;50:99-106

A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.

Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson A-L; Bomfim IL; Fink K; Lernmark Å
Article: PLOS PATHOGENS. 2014;10(4):e1004084

JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants.

Sundqvist E; Buck D; Warnke C; Albrecht E; Gieger C; Khademi M; Lima Bomfim I; Fogdell-Hahn A; Link J; Alfredsson L; Søndergaard HB; Hillert J; International Multiple Sclerosis Genetics Consorti; Oturai AB; Hemmer B; Kockum I; Olsson T
Article: MOLECULAR & CELLULAR PROTEOMICS. 2013;12(9):2657-2672

Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.

Ayoglu B; Häggmark A; Khademi M; Olsson T; Uhlén M; Schwenk JM; Nilsson P
Article: PROTEOMICS. 2013;13(15):2256-2267

Antibody-based profiling of cerebrospinal fluid within multiple sclerosis.

Häggmark A; Byström S; Ayoglu B; Qundos U; Uhlén M; Khademi M; Olsson T; Schwenk JM; Nilsson P
Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(7):877-884

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.

Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(7):863-870

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.

Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T
Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(7):871-876

Serum levels of LIGHT in MS.

Malmeström C; Gillett A; Jernås M; Khademi M; Axelsson M; Kockum I; Mattsson N; Zetterberg H; Blennow K; Alfredsson L; Wadenvik H; Lycke J; Olsson T; Olsson B
Article: LUPUS. 2013;22(3):307-311

Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

Iacobaeus E; Hopia L; Khademi M; Lundén M; Hammarin A-L; Svenungsson E; Andersson M
Article: JOURNAL OF PROTEOME RESEARCH. 2013;12(3):1101-1107

Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients.

Stoop MP; Singh V; Stingl C; Martin R; Khademi M; Olsson T; Hintzen RQ; Luider TM
Article: PLOS ONE. 2013;8(3):e57820

Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.

Romme Christensen J; Börnsen L; Ratzer R; Piehl F; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
Article: PLOS ONE. 2013;8(5):e63172

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

Khademi M; Dring AM; Gilthorpe JD; Wuolikainen A; Al Nimer F; Harris RA; Andersson M; Brundin L; Piehl F; Olsson T; Svenningsson A
Article: NEUROLOGY. 2012;79(23):2241-2248

Neurofascin as a target for autoantibodies in peripheral neuropathies.

Ng JKM; Malotka J; Kawakami N; Derfuss T; Khademi M; Olsson T; Linington C; Odaka M; Tackenberg B; Prüss H; Schwab JM; Harms L; Harms H; Sommer C; Rasband MN; Eshed-Eisenbach Y; Peles E; Hohlfeld R; Yuki N; Dornmair K; Meinl E
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2012;170(2):149-155

FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.

Sellebjerg F; Krakauer M; Khademi M; Olsson T; Sørensen PS
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(31):12728-12733

Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.

Lampa J; Westman M; Kadetoff D; Agréus AN; Le Maître E; Gillis-Haegerstrand C; Andersson M; Khademi M; Corr M; Christianson CA; Delaney A; Yaksh TL; Kosek E; Svensson CI
Article: JOURNAL OF NEUROINFLAMMATION. 2012;9:167

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.

Gonzalez H; Khademi M; Borg K; Olsson T
Article: SCIENCE TRANSLATIONAL MEDICINE. 2012;4(137):137ra73

Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation.

Ho PP; Kanter JL; Johnson AM; Srinagesh HK; Chang E-J; Purdy TM; van Haren K; Wikoff WR; Kind T; Khademi M; Matloff LY; Narayana S; Hur EM; Lindstrom TM; He Z; Fiehn O; Olsson T; Han X; Han MH; Steinman L; Robinson WH
Article: GENOME MEDICINE. 2012;4(1):2

The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls.

Ronninger M; Guo Y; Shchetynsky K; Hill A; Khademi M; Olsson T; Reddy PS; Seddighzadeh M; Clark JD; Lin L-L; O'Toole M; Padyukov L
Article: HLA. 2011;78(4):271-274

No evidence of IL21 association with multiple sclerosis in a Swedish population.

Lindén M; Nohra R; Sundqvist E; Khademi M; Hillert J; Alfredsson L; Olsson T; Kockum I
Article: JOURNAL OF INTERNAL MEDICINE. 2011;270(3):229-236

Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.

Mälarstig A; Silveira A; Wågsäter D; Öhrvik J; Bäcklund A; Samnegård A; Khademi M; Hellenius M-L; Leander K; Olsson T; Uhlén M; de Faire U; Eriksson P; Hamsten A
Article: NEUROLOGY. 2011;77(6):580-588

Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.

Pröbstel AK; Dornmair K; Bittner R; Sperl P; Jenne D; Magalhaes S; Villalobos A; Breithaupt C; Weissert R; Jacob U; Krumbholz M; Kuempfel T; Blaschek A; Stark W; Gärtner J; Pohl D; Rostasy K; Weber F; Forne I; Khademi M; Olsson T; Brilot F; Tantsis E; Dale RC; Wekerle H; Hohlfeld R; Banwell B; Bar-Or A; Meinl E; Derfuss T
Article: PLOS ONE. 2011;6(5):e19138

The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis.

Iacobaeus E; Amoudruz P; Ström M; Khademi M; Brundin L; Hillert J; Kockum I; Malmström V; Olsson T; Tham E; Piehl F
Article: MULTIPLE SCLEROSIS JOURNAL. 2011;17(3):335-343

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2011;40(5):363-372

Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.

Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
Article: JOURNAL OF LIPID RESEARCH. 2011;52(1):170-174

High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?

Björkhem I; Lövgren-Sandblom A; Piehl F; Khademi M; Pettersson H; Leoni V; Olsson T; Diczfalusy U
Article: MULTIPLE SCLEROSIS JOURNAL. 2011;17(1):32-42

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.

Börnsen L; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
Article: JOURNAL OF IMMUNOLOGY. 2010;185(6):3574-3582

Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block.

Strandberg LS; Ambrosi A; Jagodic M; Dzikaite V; Janson P; Khademi M; Salomonsson S; Ottosson L; Klauninger R; Adén U; Sonesson S-E; Sunnerhagen M; de Graaf KL; Kuchroo VK; Achour A; Winqvist O; Olsson T; Wahren-Herlenius M
Article: MULTIPLE SCLEROSIS JOURNAL. 2010;16(9):1056-1065

Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.

Gillett A; Thessen Hedreul M; Khademi M; Espinosa A; Beyeen AD; Jagodic M; Kockum I; Harris RA; Olsson T
Article: GENES AND IMMUNITY. 2010;11(4):279-293

RGMA and IL21R show association with experimental inflammation and multiple sclerosis.

Nohra R; Beyeen AD; Guo JP; Khademi M; Sundqvist E; Hedreul MT; Sellebjerg F; Smestad C; Oturai AB; Harbo HF; Wallström E; Hillert J; Alfredsson L; Kockum I; Jagodic M; Lorentzen J; Olsson T
Article: NEUROBIOLOGY OF DISEASE. 2010;37(3):613-621

Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K
Article: SCIENCE TRANSLATIONAL MEDICINE. 2009;1(10):10ra21

A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis.

Jagodic M; Colacios C; Nohra R; Dejean AS; Beyeen AD; Khademi M; Casemayou A; Lamouroux L; Duthoit C; Papapietro O; Sjöholm L; Bernard I; Lagrange D; Dahlman I; Lundmark F; Oturai AB; Soendergaard HB; Kemppinen A; Saarela J; Tienari PJ; Harbo HF; Spurkland A; Ramagopalan SV; Sadovnick DA; Ebers GC; Seddighzadeh M; Klareskog L; Alfredsson L; Padyukov L; Hillert J; Clanet M; Edan G; Fontaine B; Fournié GJ; Kockum I; Saoudi A; Olsson T
Article: NEUROLOGY. 2009;73(23):2003-2010

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
Article: PLOS ONE. 2009;4(8):e6534

Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system.

Vudattu NK; Kuhlmann-Berenzon S; Khademi M; Seyfert V; Olsson T; Maeurer MJ
Article: JOURNAL OF IMMUNOLOGY. 2009;182(11):6889-6895

TLR activation induces TNF-alpha production from adult neural stem/progenitor cells.

Covacu R; Arvidsson L; Andersson A; Khademi M; Erlandsson-Harris H; Harris RA; Svensson MA; Olsson T; Brundin L
Article: RESPIRATORY RESEARCH. 2009;10(1):42

Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis.

Idali F; Wahlström J; Dahlberg B; Khademi M; Olsson T; Eklund A; Grunewald J
Article: NEUROLOGY. 2009;72(15):1322-1329

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.

Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJA; Schepens M; Bouwman F; Twaalfhoven HAM; Blom HJ; Jakobs C; Dijkstra CD
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2009;16(4):528-536

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.

Khademi M; Bornsen L; Rafatnia F; Andersson M; Brundin L; Piehl F; Sellebjerg F; Olsson T
Article: JOURNAL OF PROTEOMICS. 2009;71(6):670-681

Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation.

Gonzalez H; Ottervald J; Nilsson KC; Sjögren N; Miliotis T; Von Bahr H; Khademi M; Eriksson B; Kjellström S; Vegvari A; Harris R; Marko-Varga G; Borg K; Nilsson J; Laurell T; Olsson T; Franzén B
Article: MULTIPLE SCLEROSIS JOURNAL. 2009;15(1):28-35

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Iacobaeus E; Ryschkewitsch C; Gravell M; Khademi M; Wallstrom E; Olsson T; Brundin L; Major E
Article: MULTIPLE SCLEROSIS JOURNAL. 2008;14(5):622-630

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.

Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2008;15(3):309-312

Induction of systemic TNFalpha in natalizumab-treated multiple sclerosis.

Khademi M; Stol D; Olsson T; Wallström E
Article: NATURE GENETICS. 2007;39(9):1108-1113

Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Lundmark F; Duvefelt K; Iacobaeus E; Kockum I; Wallström E; Khademi M; Oturai A; Ryder LP; Saarela J; Harbo HF; Celius EG; Salter H; Olsson T; Hillert J
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2006;64(6):609-622

Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis.

Tham E; Gielen AW; Khademi M; Martin C; Piehl F
Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(9):1237-1240

No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab.

Andersson M; Svenungsson E; Khademi M; Lampa J; Brundin L; Wallström E
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2006;64(2):155-163

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
Article: JOURNAL OF NEUROINFLAMMATION. 2005;2:26

Cytokine responses during chronic denervation.

Ruohonen S; Khademi M; Jagodic M; Taskinen H-S; Olsson T; Röyttä M
Article: JOURNAL OF NEUROIMMUNOLOGY. 2005;165(1-2):192-200

Immunological patterns identifying disease course and evolution in multiple sclerosis patients.

Furlan R; Rovaris M; Martinelli Boneschi F; Khademi M; Bergami A; Gironi M; Deleidi M; Agosta F; Franciotta D; Scarpini E; Uccelli A; Zaffaroni M; Kurne A; Comi G; Olsson T; Filippi M; Martino G
Article: JOURNAL OF NEUROIMMUNOLOGY. 2005;164(1-2):93-104

Expression of T cell immunoglobulin- and mucin-domain-containing molecules-1 and -3 (TIM-1 and -3) in the rat nervous and immune systems.

Gielen AW; Lobell A; Lidman O; Khademi M; Olsson T; Piehl F
Article: NATURE GENETICS. 2005;37(5):486-494

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.

Swanberg M; Lidman O; Padyukov L; Eriksson P; Akesson E; Jagodic M; Lobell A; Khademi M; Börjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
Article: JOURNAL OF NEUROTRAUMA. 2004;21(7):969-975

Distinct expression of TGF-beta1 mRNA in the endo- and epineurium after nerve injury.

Taskinen HS; Ruohonen S; Jagodic M; Khademi M; Olsson T; Röyttä M
Article: JOURNAL OF IMMUNOLOGY. 2004;172(11):7169-7176

T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.

Khademi M; Illés Z; Gielen AW; Marta M; Takazawa N; Baecher-Allan C; Brundin L; Hannerz J; Martin C; Harris RA; Hafler DA; Kuchroo VK; Olsson T; Piehl F; Wallström E
Article: JOURNAL OF NEUROIMMUNOLOGY. 2004;150(1-2):139-144

Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.

Gonzalez H; Khademi M; Andersson M; Piehl F; Wallström E; Borg K; Olsson T
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2003;57(5):493-497

Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients.

Gielen A; Khademi M; Muhallab S; Olsson T; Piehl F
Article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2003;58(1):49-59

In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy.

Matthiesen L; Khademi M; Ekerfelt C; Berg G; Sharma S; Olsson T; Ernerudh J
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2002;205(1):9-13

Prior poliomyelitis-evidence of cytokine production in the central nervous system.

Gonzalez H; Khademi M; Andersson M; Wallström E; Borg K; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 2002;132(1-2):11-17

Contralateral non-operated nerve to transected rat sciatic nerve shows increased expression of IL-1beta, TGF-beta1, TNF-alpha, and IL-10.

Ruohonen S; Jagodi M; Khademi M; Taskinen H-S; Ojala P; Olsson T; Röyttä M
Article: ANNALS OF NEUROLOGY. 2002;51(4):467-474

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.

Killestein J; Olsson T; Wallström E; Svenningsson A; Khademi M; Blumhardt LD; Fagius J; Hillert J; Landtblom A-M; Edenius C; Arfors L; Barkhof F; Polman CH
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2002;9(2):153-164

Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis.

Olsson T; Edenius C; Ferm M; Samuelson P; Torrång A; Wallström E; Khademi M; Andersson M; Arfors L
Article: JOURNAL OF NEUROIMMUNOLOGY. 2001;116(2):168-177

Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis.

Di Marco R; Khademi M; Wallstrom E; Iacobaeus E; Salvaggio A; Caracappa S; Papoian R; Nicoletti F; Olsson T
Article: ANNALS OF THE RHEUMATIC DISEASES. 2001;60(4):372-379

Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.

Svenungsson E; Andersson M; Brundin L; van Vollenhoven R; Khademi M; Tarkowski A; Greitz D; Dahlström M; Lundberg I; Klareskog L; Olsson T
Article: ANNALS OF THE RHEUMATIC DISEASES. 2000;59(6):439-447

Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

Ulfgren AK; Gröndal L; Lindblad S; Khademi M; Johnell O; Klareskog L; Andersson U
Article: JOURNAL OF NEUROIMMUNOLOGY. 2000;103(2):202-210

Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis.

Khademi M; Wallström E; Andersson M; Piehl F; Di Marco R; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 2000;102(1):17-25

Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA.

Taskinen HS; Olsson T; Bucht A; Khademi M; Svelander L; Röyttä M
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2000;7(1):71-76

Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+ and the CD8+ subsets.

Wallström E; Khademi M; Andersson M; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 1999;101(1):87-97

Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death.

Piehl F; Lundberg C; Khademi M; Bucht A; Dahlman I; Lorentzen JC; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 1999;101(1):76-86

Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons.

Lindå H; Hammarberg H; Piehl F; Khademi M; Olsson T
Article: JOURNAL OF AUTOIMMUNITY. 1999;13(2):187-195

Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10.

Di Marco R; Khademi M; Wallstrom E; Muhallab S; Nicoletti F; Olsson T
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1998;28(10):3329-3335

Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis.

Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
Article: EXPERIMENTAL NEUROLOGY. 1998;150(2):282-295

Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy.

Lindå H; Hammarberg H; Cullheim S; Levinovitz A; Khademi M; Olsson T
Article: EUROPEAN JOURNAL OF NEUROLOGY. 1997;4(6):567-571

Cytokine profile in interferon-β treated multiple sclerosis patients:: reduction of interleukin-10 mRNA expressing cells in peripheral blood

Andersson M; Khademi M; Wallstrom E; Olsson T
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 1996;137(2):89-96

Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis.

Wallström E; Diener P; Ljungdahl A; Khademi M; Nilsson CG; Olsson T
Visa fler

Alla övriga publikationer

Review: JAMA NEUROLOGY. 2019;76(9):1035-1048

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

Bridel C; van Wieringen WN; Zetterberg H; Tijms BM; Teunissen CE; and the NFL Group; Alvarez-Cermeño JC; Andreasson U; Axelsson M; Bäckström DC; Bartos A; Bjerke M; Blennow K; Boxer A; Brundin L; Burman J; Christensen T; Fialová L; Forsgren L; Frederiksen JL; Gisslén M; Gray E; Gunnarsson M; Hall S; Hansson O; Herbert MK; Jakobsson J; Jessen-Krut J; Janelidze S; Johannsson G; Jonsson M; Kappos L; Khademi M; Khalil M; Kuhle J; Landén M; Leinonen V; Logroscino G; Lu C-H; Lycke J; Magdalinou NK; Malaspina A; Mattsson N; Meeter LH; Mehta SR; Modvig S; Olsson T; Paterson RW; Pérez-Santiago J; Piehl F; Pijnenburg YAL; Pyykkö OT; Ragnarsson O; Rojas JC; Romme Christensen J; Sandberg L; Scherling CS; Schott JM; Sellebjerg FT; Simone IL; Skillbäck T; Stilund M; Sundström P; Svenningsson A; Tortelli R; Tortorella C; Trentini A; Troiano M; Turner MR; van Swieten JC; Vågberg M; Verbeek MM; Villar LM; Visser PJ; Wallin A; Weiss A; Wikkelsø C; Wild EJ
Letter: JOURNAL OF INTERNAL MEDICINE. 2011;270(5):496-499

Inflammatory and haemostatic markers in idiopathic intracranial hypertension.

Hannerz J; Antovic JP; Blombäck M; Edman G; Khademi M; Piehl F
Published paper: JOURNAL OF PROTEOMICS. 2010;73(6):1117-1132

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.

Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
Review: JOURNAL OF LEUKOCYTE BIOLOGY. 2008;84(5):1248-1255

Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

Andersson A; Covacu R; Sunnemark D; Danilov AI; Dal Bianco A; Khademi M; Wallström E; Lobell A; Brundin L; Lassmann H; Harris RA
Meeting abstract: CLINICAL IMMUNOLOGY. 2006;119:S119-S120

Increased expression of interleukin-10, tumor necrosis factor and interleukin-23 in Multiple Sclerosis patients treated with interferon-β.

Krakauer M; Khademi M; Sorensen P; Olsson T; Sellebjerg F
Meeting abstract: CLINICAL IMMUNOLOGY. 2006;119:S116-S117

Interleukin-7 receptor (IL-7R) mediated signaling effects in immune cells:novel readout for 'immune competence'

Vudattu N; Magalhaes I; Ahmed R; Schmidt M; Khademi M; Olsson T; Maeurer M

Anställningar

Senior Lab Manager, Klinisk neurovetenskap, Karolinska Institutet, 2022-

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2005

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI